Suppr超能文献

基于变性高效液相色谱法的意大利遗传性出血性毛细血管扩张症患者ENG和ALK-1基因突变分析

DHPLC-based mutation analysis of ENG and ALK-1 genes in HHT Italian population.

作者信息

Lenato Gennaro M, Lastella Patrizia, Di Giacomo Marilena C, Resta Nicoletta, Suppressa Patrizia, Pasculli Giovanna, Sabbà Carlo, Guanti Ginevra

机构信息

Dipartimento di Biomedicina dell'età Evolutiva, Policlinico, Piazza Giulio Cesare, 70124, Bari, Italy.

出版信息

Hum Mutat. 2006 Feb;27(2):213-4. doi: 10.1002/humu.9400.

Abstract

Hereditary haemorrhagic telangiectasia (HHT or Rendu-Osler-Weber syndrome) is an autosomal dominant disorder characterized by localized angiodysplasia due to mutations in endoglin, ALK-1 gene, and a still unidentified locus. The lack of highly recurrent mutations, locus heterogeneity, and the presence of mutations in almost all coding exons of the two genes makes the screening for mutations time-consuming and costly. In the present study, we developed a DHPLC-based protocol for mutation detection in ALK1 and ENG genes through retrospective analysis of known sequence variants, 20 causative mutations and 11 polymorphisms, and a prospective analysis on 47 probands with unknown mutation. Overall DHPLC analysis identified the causative mutation in 61 out 66 DNA samples (92.4%). We found 31 different mutations in the ALK1 gene, of which 15 are novel, and 20, of which 12 are novel, in the ENG gene, thus providing for the first time the mutational spectrum in a cohort of Italian HHT patients. In addition, we characterized the splicing pattern of ALK1 gene in lymphoblastoid cells, both in normal controls and in two individuals carrying a mutation in the non-invariant -3 position of the acceptor splice site upstream exon 6 (c.626-3C>G). Functional essay demonstrated the existence, also in normal individuals, of a small proportion of ALK1 alternative splicing, due to exon 5 skipping, and the presence of further aberrant splicing isoforms in the individuals carrying the c.626-3C>G mutation.

摘要

遗传性出血性毛细血管扩张症(HHT或朗杜-奥斯勒-韦伯综合征)是一种常染色体显性疾病,其特征为因内皮糖蛋白、ALK-1基因及一个尚未明确的基因座发生突变而导致的局限性血管发育异常。由于缺乏高度复发性突变、基因座异质性以及这两个基因几乎所有编码外显子中均存在突变,使得突变筛查既耗时又昂贵。在本研究中,我们通过对已知序列变异、20个致病突变和11个多态性进行回顾性分析,以及对47名未知突变的先证者进行前瞻性分析,开发了一种基于变性高效液相色谱(DHPLC)的方法来检测ALK1和ENG基因中的突变。总体而言,DHPLC分析在66个DNA样本中的61个(92.4%)中鉴定出了致病突变。我们在ALK1基因中发现了31种不同的突变,其中15种是新发现的;在ENG基因中发现了20种,其中12种是新发现的,从而首次提供了一组意大利HHT患者的突变谱。此外,我们对正常对照以及两名在第6外显子上游受体剪接位点非恒定-3位置携带突变(c.626-3C>G)的个体的淋巴母细胞中ALK1基因的剪接模式进行了表征。功能分析表明,在正常个体中也存在一小部分由于第5外显子跳跃导致的ALK1可变剪接,并且在携带c.626-3C>G突变的个体中存在进一步的异常剪接异构体。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验